These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7836061)

  • 21. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvariation creates significant functional differences in the DR3 molecules.
    Posch PE; Araujo HA; Creswell K; Praud C; Johnson AH; Hurley CK
    Hum Immunol; 1995 Jan; 42(1):61-71. PubMed ID: 7751161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules.
    Mycko MP; Waldner H; Anderson DE; Bourcier KD; Wucherpfennig KW; Kuchroo VK; Hafler DA
    J Immunol; 2004 Aug; 173(3):1689-98. PubMed ID: 15265898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis.
    Penzotti JE; Nepom GT; Lybrand TP
    Arthritis Rheum; 1997 Jul; 40(7):1316-26. PubMed ID: 9214433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
    Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
    J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues.
    Brawley JV; Concannon P
    J Exp Med; 1996 May; 183(5):2043-51. PubMed ID: 8642315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biased T-cell receptor usage is associated with allelic variation in the MHC class II peptide binding groove.
    Yassine-Diab B; Carmichael P; L'Faqihi FE; Lombardi G; Deacock S; de Préval C; Coppin H; Lechler RI
    Immunogenetics; 1999 Jun; 49(6):532-40. PubMed ID: 10380698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the T-cell receptors utilized for allogeneic HLA-DR recognition: comparison of different responder-cell donors possessing an identical HLA-DR allele.
    Obata F; Tsunoda-Iizuka M
    Scand J Immunol; 1998 Oct; 48(4):364-70. PubMed ID: 9790306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.
    Gamerdinger K; Moulon C; Karp DR; Van Bergen J; Koning F; Wild D; Pflugfelder U; Weltzien HU
    J Exp Med; 2003 May; 197(10):1345-53. PubMed ID: 12756270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS; van Rood JJ; Termijtelen A
    Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
    Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
    J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.